Overview
Background
Professor Rachel Thomson is a Head of the Greenslopes Clinical Unit, Thoracic Physician and clinical researcher working at Greenslopes Private Hospital.
She has an international reputation in the area of Pulmonary Nontuberculous mycobacterial disease. She has published widely in the area and is regularly invited to speak at international and national meetings.https://medical-school.uq.edu.au/research/ntm-research-group
Her current research focuses on immunological and environmental aspects of susceptibility to NTM infection, characteristics of the lung and gut microbiome in NTM, and improving treatment outcomes.
In a clinical capacity, Professor Thomson is able to offer patients expert management of their disease at Pulmedica, Greenslopes Private Hospital, at public clinics at The Prince Charles Hospital and the MetroSouth Clinical TB service of the Princess Alexandra Hospital and via telehealth for patients across Australia. Patients can also access novel treatments through clinical trials in both the private and public sector.
Prof Thomson also has a special interest in respiratory problems of the elite athlete. This includes asthma management, vocal cord dysfunction, and the requirements of national and international doping organisations for asthma medications.
Availability
- Professor Rachel Thomson is:
- Available for supervision
- Media expert
Fields of research
Research interests
-
Pulmonary nontuberculous mycobacterial disease
-
Genetic relatedness of mycobacterial strains
-
Environmental ecology of mycobacteria
Works
Search Professor Rachel Thomson’s works on UQ eSpace
2019
Conference Publication
Influence of Climate Variables on the Rising Incidence of Nontuberculous Mycobacterial (NTM) Infections in Queensland, Australia 2001-2016
Thomson, R., Furuya-Kanamori, L., Coffey, C., Bell, S., Knibbs, L. and Lau, C. (2019). Influence of Climate Variables on the Rising Incidence of Nontuberculous Mycobacterial (NTM) Infections in Queensland, Australia 2001-2016. International Conference of the American-Thoracic-Society, Dallas, TX United States, 17-22 May 2019. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2043
2019
Conference Publication
Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients
Thomson, R., Scoleri, G., Taylor, S., Leong, L., Burr, L. and Rogers, G. (2019). Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1035
2019
Conference Publication
Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study
Griffith, D. E., Thomson, R., Addrizzo-Harris, D. J., Field, S. K., van Ingen, J., Wallace, R. J., Coulter, C., Mange, K., Nezamis, J. and Winthrop, K. L. (2019). Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7359
2018
Conference Publication
The clinical significance of Mycobacterium triplex isolates in Queensland, Australia
Gibson, Justine, Baird, Tim, Pandy, Sushil, Tolson, Carla, Coulter, Chris, Eather, Geoffrey and Thomson, Rachel (2018). The clinical significance of Mycobacterium triplex isolates in Queensland, Australia. 28th International Congress of the European-Respiratory-Society (ERS), Paris France, Sep 15-19, 2018. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2018.PA344
2018
Journal Article
Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study
Griffith, David E., Eagle, Gina, Thomson, Rachel, Aksamit, Timothy R., Hasegawa, Naoki, Morimoto, Kozo, Addrizzo-Harris, Doreen J., O'Donnell, Anne E., Marras, Theodore K., Flume, Patrick A., Loebinger, Michael R., Morgan, Lucy, Codecasa, Luigi R., Hill, Adam T., Ruoss, Stephen J., Yim, Jae-Joon, Ringshausen, Felix C., Field, Stephen K., Philley, Julie V., Wallace, Jr., Richard J., van Ingen, Jakko, Coulter, Chris, Nezamis, James and Winthrop, Kevin L. (2018). Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study. American Journal of Respiratory and Critical Care Medicine, 198 (12) rccm.201807-1318OC, 1559-1569. doi: 10.1164/rccm.201807-1318oc
2018
Conference Publication
Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis
Stockwell, R. E., Leong, L., Wood, M. E., Sherrard, L., Carter, R., Tolson, C., Thomson, R., Rogers, G., Wainwright, C. and Bell, S. C. (2018). Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Denver, CO, United States, 18-20 October 2018. Hoboken, NJ, United States: John Wiley & Sons.
2018
Conference Publication
PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION
Stockwell, R. E., Leong, L., Wheeler, N., Bryant, J., Wood, M. E., Sherrard, L., Thomson, R., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2018). PREVALENCE OF SHARED MYCOBACTERIUM ABSCESSUS COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION. HOBOKEN: WILEY.
2018
Journal Article
Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection
Lutzky, Viviana P., Ratnatunga, Champa N., Smith, Daniel J., Kupz, Andreas, Doolan, Denise L., Reid, David W., Thomson, Rachel M., Bell, Scott C. and Miles, John J. (2018). Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection. Frontiers in Immunology, 9 (June) 1319, 1319. doi: 10.3389/fimmu.2018.01319
2018
Journal Article
Sleep disturbances in Australian Vietnam veterans with and without posttraumatic stress disorder
Baird, Timothy, McLeay, Sarah, Harvey, Wendy, Theal, Rebecca, Law, Dayna, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, Young, Ross, Dwyer, Miriam, Gibson, John, O'Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher, Thomson, Rachel, Voisey, Joanne and Lawford, Bruce (2018). Sleep disturbances in Australian Vietnam veterans with and without posttraumatic stress disorder. Journal of Clinical Sleep Medicine, 14 (5), 745-752. doi: 10.5664/jcsm.7096
2018
Journal Article
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
van Ingen, Jakko, Aksamit, Timothy, Andrejak, Claire, Bottger, Erik C., Cambau, Emmanuelle, Daley, Charles L., Griffith, David E., Guglielmetti, Lorenzo, Holland, Steven M., Huitt, Gwen A., Koh, Won-Jung, Lange, Christoph, Leitman, Philip, Marras, Theodore K., Morimoto, Kozo, Olivier, Kenneth N., Santin, Miguel, Stout, Jason E., Thomson, Rachel, Tortoli, Enrico, Wallace, Richard J., Winthrop, Kevin L. and Wagner, Dirk (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. European Respiratory Journal, 51 (3) 1800170, 1800170. doi: 10.1183/13993003.00170-2018
2018
Journal Article
Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis
Choo, Jocelyn M., Abell, Guy C. J., Thomson, Rachel, Morgan, Lucy, Waterer, Grant, Gordon, David L., Taylor, Steven L., Leong, Lex E. X., Wesselingh, Steve L., Burr, Lucy D. and Rogers, Geraint B. (2018). Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis. mSphere, 3 (2) e00103-18, e00103-18. doi: 10.1128/mSphere.00103-18
2018
Conference Publication
Prevalence of nontuberculous mycobacteria (NTM) in potable water
Stockwell, R., Leong, L., Wood, M., Sherrard, L., Thomson, R., Rogers, G. and Bell, S. (2018). Prevalence of nontuberculous mycobacteria (NTM) in potable water. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell.
2018
Conference Publication
Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients
Griffith, D. E., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Castellotti, P. F., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Winthrop, K. L. (2018). Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients. International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.
2018
Journal Article
Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease
Baird, Timothy M. and Thomson, Rachel (2018). Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease. ERS Monograph, 2018, 204-221. doi: 10.1183/2312508X.10014818
2018
Conference Publication
Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)
Winthrop, K. L., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Griffith, D. E. (2018). Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC). International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.
2017
Journal Article
Mycobacterium shimoidei, a rare pulmonary pathogen, Queensland, Australia
Baird, Timothy M., Carter, Robyn, Eather, Geoffrey and Thomson, Rachel (2017). Mycobacterium shimoidei, a rare pulmonary pathogen, Queensland, Australia. Emerging Infectious Diseases, 23 (11), 1919-1922. doi: 10.3201/eid2311.170999
2017
Book Chapter
Mycobacteria other than TB
Thomson, Rachel (2017). Mycobacteria other than TB. Management of tuberculosis: a guide for clinicians. (pp. 160-170) edited by Justin Denholm, Alan Street and Emma McBride. Canberra, ACT, Australia: Australasian Tuberculosis Program.
2017
Journal Article
Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans
McLeay, Sarah C., Harvey, Wendy M., Romaniuk, Madeline N. M., Crawford, Darrell H. G., Colquhoun, David M., Young, Ross McD., Dwyer, Miriam, Gibson, John M., O'Sullivan, Robyn A., Cooksley, Graham, Strakosch, Christopher R., Thomson, Rachel M., Voisey, Joanne and Lawford, Bruce R. (2017). Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans. Medical Journal of Australia, 206 (6), 251-257. doi: 10.5694/mja16.00935
2017
Journal Article
Notification of nontuberculous mycobacteria: an Australian perspective
Thomson, Rachel, Donnan, Ellen and Konstantinos, Anastasios (2017). Notification of nontuberculous mycobacteria: an Australian perspective. Annals of the American Thoracic Society, 14 (3), 318-323. doi: 10.1513/AnnalsATS.201612-994OI
2017
Journal Article
A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease
Halstrom, Samuel, Cherry, Catherine L., Black, Michael, Thomson, Rachel, Goullee, Hayley, Baltic, Svetlana, Allcock, Richard, Temple, Suzanna E. L. and Price, Patricia (2017). A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease. Immunogenetics, 69 (5), 1-7. doi: 10.1007/s00251-017-0972-z
Funding
Current funding
Past funding
Supervision
Availability
- Professor Rachel Thomson is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Transmission dynamics of multi-drug resistant tuberculosis amongst immune suppressed patients exposed to an infectious case
Principal Advisor
Other advisors: Professor Antje Blumenthal
-
Doctor Philosophy
The nature of the relationship between patient and environmental isolates of Mycobacterium intracellulare in Queensland.
Principal Advisor
-
Master Philosophy
The gut-lung axis in nontuberculous mycobacterial pulmonary disease.
Principal Advisor
Other advisors: Professor Mark Morrison, Professor Antje Blumenthal
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Associate Advisor
Other advisors: Professor Scott Bell
-
Doctor Philosophy
Pharmacokinetics of anti-mycobacterial drugs in patients with cystic fibrosis
Associate Advisor
Other advisors: Professor Scott Bell, Professor Jason Roberts
Completed supervision
-
2017
Master Philosophy
Environmental transmission factors and host genetic polymorphisms influencing NTM infection in patients with no overt immunodeficiency
Principal Advisor
Media
Enquiries
Contact Professor Rachel Thomson directly for media enquiries about:
- Mycobacterial diseases
- mycobacterial infections
- Pulmonary Nontuberculous mycobacterial infections
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: